Lawmakers are trying to restore access to GLP-1 weight loss drugs, like Ozempic and Wegovy, after Ohio removed medical ...

Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as ...

According to a new report from Big Chalk Analytics, GLP-1 users have cut $6.5 billion from U.S. grocery spend.

In what Science magazine has dubbed “Novo Nordisk’s Canadian Mistake,” Ozempic is soon to come off patent in Canada, opening ...

Fractyl Health offers a high-risk, high-reward setup with a near-term binary catalyst in the REMAIN-1 cohort data expected Q3 ...

Offering a rare glimpse inside the hidden world of rejected insurance claims, new data shows a steady uptick among major ...

With Gov. Patrick Morrisey’s first special session of 2025 likely to be focused on health care costs for public employees, lawmakers will have to contend with what to do about the Public Employees ...

People who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...

With their lengthening laundry list of health benefits, drugs like Ozempic are showing promise for people who struggle with addiction.

People who buy health insurance through the Affordable Care Act (ACA) could see a major spike in their premiums next year, at ...

Battered by multiple years of high health care costs, employers are planning to shift more of the expense to workers in 2026, a new survey released Wednesday found.

Ozempic has taken the world by storm as a weight-loss and diabetes drug—but what’s the full story? In this eye-opening ...